Moreover, significant research has been conducted on the role of Fibroblast Growth Factor 23 (FGF23) in the pathophysiologic axis of anemia and inflammation, especially in chronic kidney disease (CKD). This evidence concerns the gene FGF23 and anemia (phenotype).